GMPKit Logo
Back to Field Guide
GMPWit™ Whitepaper | Structured Productivity in GMP Environments

GMPWit™ Whitepaper | Structured Productivity in GMP Environments

By Paul Van Buskirk, Mike Barlow
GMPWit™ introduces structured productivity to GMP environments, improving how deviation investigations, CAPAs, and operational work are created—without impacting validated systems or regulatory compliance.

Document Control

Document Title
GMPWit™ System Impact Assessment Whitepaper

Document Number
ENG-102076

Version
1.0

Author
GMPKit, LLC.

Approval Authority
GMPKit Quality & Compliance

Original Publication Date
January 2026

Document Purpose
This whitepaper summarizes the System Impact Assessment (SIA) performed for the GMPWit™ platform and explains how the system aligns with recognized regulatory guidance for computerized systems used in regulated pharmaceutical manufacturing environments.

Structured Productivity in GMP Environments

Executive Summary

GMP environments are not constrained by a lack of systems — they are constrained by how effectively people think, structure, and execute work within those systems.

GMPWit™ is an AI-enabled platform designed to improve structured thinking, framework-based execution, and measurable productivity in regulated manufacturing environments.

Unlike traditional digital systems, GMPWit™ does not execute GMP workflows or act as a system of record. Instead, it operates as a decision-support and structured work platform that enables users to accelerate draft creation, apply frameworks consistently, and improve the clarity and quality of output.

GMPWit™ is classified as Non-GxP (No Impact), enabling rapid deployment while maintaining alignment with GMP regulatory expectations.

The Operational Gap: Where Productivity Is Lost

Most pharmaceutical organizations invest heavily in systems such as QMS, LIMS, and MES, yet a critical gap remains — the quality and structure of human-generated work before it enters those systems.

This gap manifests as:

  • Poorly structured deviation investigations
  • Inconsistent CAPA narratives
  • Documentation rework
  • Extended review cycles
  • Misalignment across teams

These inefficiencies directly contribute to Cost of Poor Quality (COPQ), yet they are rarely measured at the source.

GMPWit™ addresses this gap by improving how work is created before it becomes regulated record.

What GMPWit™ Is (and Is Not)

What GMPWit™ Is

  • Framework-based learning and reasoning platform
  • Structured drafting environment
  • Productivity visibility tool
  • Decision-support assistant (human-in-the-loop)

What GMPWit™ Is Not

  • System of record
  • Workflow execution engine
  • GMP decision authority
  • Replacement for QMS, LIMS, MES, or eBR systems

This boundary is intentional and foundational to its regulatory positioning.

System Classification and Regulatory Position

GMPWit™ does not:

  • Control or monitor critical process parameters
  • Generate or approve GMP records
  • Influence product disposition decisions
  • Integrate into validated systems of record
As a result, GMPWit™ is classified as: Non-GxP (No Impact)

This classification means:

  • No IQ/OQ/PQ required
  • No formal validation deliverables required
  • No GMP commissioning required

Risk is managed through system boundaries, human-in-the-loop enforcement, and non-decision authority design.

Risk-Based Design (Aligned with GAMP 5)

GMPWit™ follows a risk-based design philosophy consistent with GAMP 5 principles.

Risk is mitigated through:

  • Prevention of unintended GMP reliance
  • Explicit positioning as a drafting and learning tool
  • Separation from systems of record
  • User responsibility for final decisions

This ensures productivity gains without introducing regulatory risk.

Measurable Productivity: A New Operational Lever

Traditional GMP systems measure compliance, throughput, and cycle times — but not the time required to think, structure, and create high-quality work.

GMPWit™ introduces structured productivity measurement.

Users can:

  • Track time spent on structured work
  • Compare effort versus output quality
  • Quantify time saved through framework-based execution

This allows organizations to translate productivity into measurable operational and financial impact.

COPQ Impact: Translating Productivity into Financial Value

GMPWit™ directly targets upstream drivers of Cost of Poor Quality (COPQ).

By improving the structure and clarity of GMP work, organizations can reduce:

  • Deviation investigation cycle time
  • Documentation errors and rework
  • Review and approval iterations
  • Misalignment across functions

These improvements translate into:

  • Reduced labor cost per investigation
  • Faster batch disposition timelines
  • Increased operational throughput
  • Improved Right First Time performance

Unlike traditional systems that measure outcomes, GMPWit™ improves the inputs that drive those outcomes.

Role Within the GMP Technology Stack

GMPWit™ operates upstream of validated/qualified systems and is intentionally positioned as a preparation layer within the GMP technology ecosystem.

At the execution layer, systems such as QMS, LIMS, and MES serve as systems of record where regulated data is stored, managed, and approved.

GMPWit™ sits above these systems as a preparation layer, where users develop structured thinking, draft content, and apply consistent frameworks before work enters regulated systems.

At the human layer, subject matter experts, quality professionals, and operations teams interact with both GMPWit™ and execution systems, using GMPWit™ to improve the quality and clarity of their work prior to formal submission.

This positioning ensures that GMPWit™ does not interfere with validated environments, while enabling immediate productivity gains through improved work preparation.

Deployment and Governance Model

As a Non-GxP system, GMPWit™ can be deployed without a validation lifecycle.

Key governance considerations include:

  • User access and authentication
  • Data privacy and isolation
  • Internal usage expectations
  • Optional SOP alignment defining intended use

Regulatory Alignment Appendix

GMPWit™ is designed to align with key regulatory expectations while remaining outside GxP scope.

ISPE GAMP 5 Alignment

  • Risk-based approach applied through system design
  • No reliance for GMP decision-making
  • No system-of-record functionality

EU GMP Annex 11 (Computerized Systems)

  • No impact on regulated records
  • No requirement for validation lifecycle
  • Operates outside GMP-critical processes

FDA 21 CFR Part 11

  • Does not generate or manage electronic GMP records
  • Does not require electronic signatures

EU GMP Annex 22 (AI – Emerging Guidance)

  • Human-in-the-loop enforced
  • Transparent system boundaries
  • No autonomous decision-making

This alignment demonstrates that AI-enabled systems can be deployed responsibly in GMP environments when boundaries are clearly defined.

Conclusion

GMPWit™ represents a shift in how GMP organizations approach digital enablement.

Rather than adding complexity to execution systems, it improves the quality, structure, and speed of the work that feeds them.

By maintaining strict system boundaries and a human-in-the-loop model, GMPWit™ delivers measurable productivity gains without introducing regulatory risk.

It is not a system that runs GMP operations — it is a system that improves how GMP work is created.

Tags

#Cost of Poor Quality (COPQ)#Pharmaceutical Manufacturing#Execution Stability#GAMP5#ISPE

Ready to Streamline Your Manufacturing?

GMPKit combines LEAN principles with our BatchTrak™ technology to target Cost of Poor Quality (COPQ) metrics.